researchers may have found a way to save the skin of melanoma patients by using antibiotics to target and eliminate the power plants fuelling the evasive cancer cells.
the study,
published in the journal of experimental medicine
, successfully used bacteria-destroying medicine to exploit a vulnerability that arises in cancer cells as they try to survive cancer therapy in mice.
“as the cancer evolves, some melanoma cells may escape the treatment and stop proliferating to ‘hide’ from the immune system,”
said eleonora leucci
, a cancer researcher and rna biologist at ku leuven, belgium. “these are the cells that have the potential to form a new tumour mass at a later stage.”
“in order to survive the cancer treatment, however, those inactive cells need to keep their ‘power plants’ — the mitochondria — switched on at all times. as mitochondria derive from bacteria that, over time, started living inside cells, they are very vulnerable to a specific class of antibiotics. this is what gave us the idea to use these antibiotics as anti-melanoma agents.”
to test their theory, researchers implanted patient-derived tumours into mice and then treated the cancer in two different ways: with antibiotics alone or with antibiotics in tandem with an existing melanoma therapy. “the antibiotics quickly killed many cancer cells and could thus be used to buy the precious time needed for immunotherapy to kick in,” leucci said. “in tumours that were no longer responding to targeted therapies, the antibiotics extended the lifespan of — and in some cases even cured — the mice.”